tirzepatide and kidneys (Zepbound) showed improved kidney function in obese patients with both chronic kidney disease #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https tirzepatide and kidneys confers renal

The medication works by enhancing insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways

For example, for GHK-Cu, studies suggest that a concentration of at least 1% is necessary to observe significant biological effects

The SURMOUNT 5 trial , published in the New England Journal of Medicine in 2025, provided the first head-to-head comparison

others can gain novel biological activities and thereby contribute to the various pathophysiological processes

Dr Jarred Younger, a prominent researcher in neuroinflammation and chronic pain, has publicly stated that semaglutide does reduce chronic pain via these three pathways, but also acknowledged that all the semaglutide and microglia studies I know of are in animal models theres still another step that needs to be taken. That caveat matters enormously, and its one well come back to

Supporting post-workout recovery